These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 28821630)

  • 1. IL-17A deficiency mitigates bleomycin-induced complement activation during lung fibrosis.
    Cipolla E; Fisher AJ; Gu H; Mickler EA; Agarwal M; Wilke CA; Kim KK; Moore BB; Vittal R
    FASEB J; 2017 Dec; 31(12):5543-5556. PubMed ID: 28821630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis.
    Gu H; Fisher AJ; Mickler EA; Duerson F; Cummings OW; Peters-Golden M; Twigg HL; Woodruff TM; Wilkes DS; Vittal R
    FASEB J; 2016 Jun; 30(6):2336-50. PubMed ID: 26956419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of Decay Accelerating Factor Mitigates Fibrotic Responses to Lung Injury.
    Vittal R; Fisher AJ; Thompson EL; Cipolla EM; Gu H; Mickler EA; Varre A; Agarwal M; Kim KK; Vasko MR; Moore BB; Lama VN
    Am J Respir Cell Mol Biol; 2022 Oct; 67(4):459-470. PubMed ID: 35895592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crosstalk between TGF-β1 and complement activation augments epithelial injury in pulmonary fibrosis.
    Gu H; Mickler EA; Cummings OW; Sandusky GE; Weber DJ; Gracon A; Woodruff T; Wilkes DS; Vittal R
    FASEB J; 2014 Oct; 28(10):4223-34. PubMed ID: 24958208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
    Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B cell activating factor is central to bleomycin- and IL-17-mediated experimental pulmonary fibrosis.
    François A; Gombault A; Villeret B; Alsaleh G; Fanny M; Gasse P; Adam SM; Crestani B; Sibilia J; Schneider P; Bahram S; Quesniaux V; Ryffel B; Wachsmann D; Gottenberg JE; Couillin I
    J Autoimmun; 2015 Jan; 56():1-11. PubMed ID: 25441030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Blocking IL-17A protects against lung injury-induced pulmonary fibrosis through promoting the activation of p50NF-kappaB].
    Mi S; Li Z; Liu H; Hu ZW; Hua F
    Yao Xue Xue Bao; 2012 Jun; 47(6):739-44. PubMed ID: 22919721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-22 inhibits bleomycin-induced pulmonary fibrosis in association with inhibition of IL-17A in mice.
    Qu Z; Dou W; Zhang K; Duan L; Zhou D; Yin S
    Arthritis Res Ther; 2022 Dec; 24(1):280. PubMed ID: 36564791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential Mechanisms Underlying TGF-β-mediated Complement Activation in Lung Fibrosis.
    Fisher AJ; Cipolla E; Varre A; Gu H; Mickler EA; Vittal R
    Cell Mol Med Open Access; 2017; 3(3):. PubMed ID: 29377033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin down-regulates IL-17A mediated p53-fibrinolytic system in bleomycin induced acute lung injury in vivo.
    Gouda MM; Bhandary YP
    J Cell Biochem; 2018 Sep; 119(9):7285-7299. PubMed ID: 29775223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-17A promotes lung fibrosis through impairing mitochondrial homeostasis in type II alveolar epithelial cells.
    Xiao H; Peng L; Jiang D; Liu Y; Zhu L; Li Z; Geng J; Xie B; Huang X; Wang J; Dai H; Wang C
    J Cell Mol Med; 2022 Nov; 26(22):5728-5741. PubMed ID: 36308405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-beta1-dependent and -independent mechanisms.
    Mi S; Li Z; Yang HZ; Liu H; Wang JP; Ma YG; Wang XX; Liu HZ; Sun W; Hu ZW
    J Immunol; 2011 Sep; 187(6):3003-14. PubMed ID: 21841134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent.
    Wilson MS; Madala SK; Ramalingam TR; Gochuico BR; Rosas IO; Cheever AW; Wynn TA
    J Exp Med; 2010 Mar; 207(3):535-52. PubMed ID: 20176803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-17A contributes to HSV1 infection-induced acute lung injury in a mouse model of pulmonary fibrosis.
    Chen T; Qiu H; Zhao MM; Chen SS; Wu Q; Zhou NY; Lu LQ; Song JC; Tang DL; Weng D; Li HP
    J Cell Mol Med; 2019 Feb; 23(2):908-919. PubMed ID: 30378252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of bleomycin-induced lung fibrosis is independent of IL-16.
    Glass WG; Argentieri RL; Bracht M; Farrell FX; Das AM; Del Vecchio AM; Hogaboam CM; Murray LA
    Cytokine; 2009 Apr; 46(1):17-23. PubMed ID: 19232499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin alleviates IL-17A-mediated p53-PAI-1 expression in bleomycin-induced alveolar basal epithelial cells.
    Gouda MM; Prabhu A; Bhandary YP
    J Cell Biochem; 2018 Feb; 119(2):2222-2230. PubMed ID: 28902433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential roles of interleukin-17A in the development of skin fibrosis in mice.
    Okamoto Y; Hasegawa M; Matsushita T; Hamaguchi Y; Huu DL; Iwakura Y; Fujimoto M; Takehara K
    Arthritis Rheum; 2012 Nov; 64(11):3726-35. PubMed ID: 22833167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-1 and IL-23 mediate early IL-17A production in pulmonary inflammation leading to late fibrosis.
    Gasse P; Riteau N; Vacher R; Michel ML; Fautrel A; di Padova F; Fick L; Charron S; Lagente V; Eberl G; Le Bert M; Quesniaux VF; Huaux F; Leite-de-Moraes M; Ryffel B; Couillin I
    PLoS One; 2011; 6(8):e23185. PubMed ID: 21858022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Essential roles for angiotensin receptor AT1a in bleomycin-induced apoptosis and lung fibrosis in mice.
    Li X; Rayford H; Uhal BD
    Am J Pathol; 2003 Dec; 163(6):2523-30. PubMed ID: 14633624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WNT/β-catenin signaling induces IL-1β expression by alveolar epithelial cells in pulmonary fibrosis.
    Aumiller V; Balsara N; Wilhelm J; Günther A; Königshoff M
    Am J Respir Cell Mol Biol; 2013 Jul; 49(1):96-104. PubMed ID: 23526221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.